emfizz.com November 21, 2017

Stock'S Earning Overview Ocular Therapeutix, Inc. (OCUL)

17 July 2017, 08:34 | Jan Cross

Other large investors have also recently modified their holdings of the company. State Street Corp raised its stake in shares of Ocular Therapeutix by 21.8% in the fourth quarter. Cantor Fitzgerald analyst E. Piros now expects that the biopharmaceutical company will post earnings per share of ($2.09) for the year, up from their prior forecast of ($2.63). Renaissance Technologies LLC acquired a new stake in Ocular Therapeutix during the fourth quarter valued at approximately $1,214,000. Wellington Management Group LLP boosted its position in shares of Ocular Therapeutix by 35.2% in the first quarter. Parametric Portfolio Associates LLC now owns 30,582 shares of the biopharmaceutical company's stock worth $284,000 after buying an additional 401 shares during the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Ocular Therapeutix during the first quarter worth about $110,000. Berson & Corrado Investment Advisors LLC now owns 32,805 shares of the biopharmaceutical company's stock worth $304,000 after buying an additional 1,785 shares during the last quarter. The institutional investor owned 87,046 shares of the biopharmaceutical company's stock after buying an additional 17,445 shares during the period.

Research professionals at Morgan Stanley now has a $8 target on Ocular Therapeutix (NASDAQ:OCUL). (NASDAQ:OCUL) has gone stronger by 29.45%. The firm's 50-day moving average is $10.44 and its 200 day moving average is $8.94.

Ocular Therapeutix, Inc. has a one year low of $4.04 and a one year high of $11.91. The company has market cap of $174.77 million.

Ocular Therapeutix (NASDAQ:OCUL) last issued its quarterly earnings data on Friday, May 5th. The biopharmaceutical company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.48) by $0.10. The Return on Equity ratio of Ocular Therapeutix, Inc. According to these analysts, the Low Revenue Estimate for Ocular Therapeutix, Inc.is 450 Million and the High Revenue Estimate is 520 Million.

Apple's new emoji include breastfeeding mom, hijabi, bearded man
In addition, to mark World Emoji Day, Apple has changed a number of titles of its films in iMovies to emoji-only titles. As the world marks World Emoji Day , Apple has revealed its newest ones that focus on the weird and wonderful.

Dominion Diamond Corporation (NYSE:DDC) Earning Favorable News Coverage, Report Finds
The total number of shares percentage held by insiders is about 19.88% while the number of Shares % held by institutions is 56.6%. Wall Street is only getting more bullish on the stock, with 4 of analysts who cover DDC having a buy-equivalent rating.

Egypt attacks: Two German female tourists, five policemen killed
In an alert on its website, the Embassy urged its tourists not to travel alone in Egypt or visit unofficial scenic spots. Rashed made the comments to TV talk-show host Amr Adib on his programme Kol Youm late on Saturday.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & global copyright law.

Insider Trades for Ocular Therapeutix, Inc. show that the latest trade was made on 14 Dec 2016 where Sawhney (Amarpreet), the Chief Executive Officer completed a transaction type "Buy" in which 45300 shares were traded at a price of $7.85. Morgan Stanley upgraded the shares of OCUL in report on Thursday, February 18 to "Overweight" rating. However, on July 6, 2017, an article published by Seeking Alpha claimed that Ocular Therapeutix's management had been misleading investors about manufacturing issues. Analysts have a mean recommendation of 2.80 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). At the time of writing, Shares the company recently traded 64.73% away 52-week low and noted price movement -44.11% away from the 52-week high level. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company's stock. Ocular Therapeutix now has a consensus rating of "Hold" and a consensus price target of $21.55.

Several analysts have released their opinion on Ocular Therapeutix, Inc. The Firm is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology.

Other News

Trending Now

Johnny Manziel says he's talked to teams about an National Football League comeback
He has a 57 percent career completion rate for a total of 1,675 yards, seven touchdowns and seven interceptions. The former Texas A&M Heisman Trophy victor was a first round pick of the Browns in 2014.

Thomas Lemar has the right profile for Arsenal, says Robert Pires
Arsenal's pursuit has been strong, especially considering the uncertainty surrounding the future of Alexis Sanchez at the moment. He made 34 appearances last season and was always on the Gunners' radar.

USA boosts seasonal worker visas halfway through summer season
To receive the visas, businesses must attest they would suffer irreparable harm if they can not bring in those workers. The United States government has sanctioned a crackdown on visitors with visa overstays .

Driver Charged In Deadly Grand Central Parkway Crash
Another passenger, 33-year-old Layon Campbell, also from Brooklyn, would later die at a hospital, police said. The crash happened at about 6:30 on the eastbound Grand Central Parkway near 188th Street in Jamaica Estates.

No Exceptions For Depositing Old Notes: Centre To Chief Justice Of India
Prime Minister Narendra Modi had surprised the nation on November 8 when he declared the old Rs 500 and 1000 notes invalid. A woman said that she was delivering her baby whereas another person said that there was a death in his family.

Meter-taxi operators attacking Uber drivers
Uber launched their hailing service in South Africa in 2013, attracting thousands of people to their application. Ndou said the meter taxi operators complained that it seemed Uber could do as it pleased.

Delphi, Indiana murder case: Sketch of suspect released in girls' slayings
In March, Mike Patty, grandfather of Liberty German, urged people to study those images and come forward with any information. Police believe the new evidence may help identify the man seen on the bridge in two previously released photos.

Fairmount Santrol Holdings Inc. (NYSE:FMSA) Upgraded to Neutral by Northcoast Research
The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. Average Revenue Estimate for the current quarter is $266.17 Million, according to consensus forecast of 12 analysts.

Barclays and former executives set for January trial over Qatar fundraising charges
If convicted the former executives could be facing lengthy jail terms as these offences can carry a maximum prison sentence of 10 years and a fine for the bank.

Procter & Gamble Company (NYSE:PG)
The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. Following the transaction, the insider now directly owns 43,608 shares of the company's stock, valued at $3,808,722.72.